Halachmi E, Pinkus R, Miron S, Ben-Nun A, Werkele H, Berke G
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
J Autoimmun. 1992 Aug;5(4):427-41. doi: 10.1016/0896-8411(92)90003-9.
We have shown that encephalitogenic, myelin basic protein (MBP)-specific CD4+ T cells can cause astrocyte and oligodendrocyte detachment in vitro. Similar processes may damage the central nervous system (CNS) in vivo by causing disorganization and destruction of brain tissue structure. The finding that 'bystander' allogeneic fibrosarcoma cells were detached by MBP-specific CD4+ T cells only when syngeneic astrocytes were present, suggested that a soluble cell-detaching factor (CDF) is released during the specific astrocyte-CD4+ effector interaction. In this study, CDF activity was detected in the supernatants of MBP-reactive CD4+ T cells incubated with concanavalin A or astrocytes. Lymphocyte-induced astrocyte lysis, but not detachment, was inhibited by the protein synthesis inhibitors, cycloheximide and puromycin, indicating that de novo protein synthesis is required for this type of lysis, but not for detachment. Astrocyte detachment was not inhibited, but rather augmented, by the trypsin inhibitors, soybean trypsin inhibitor (SBTI) and alpha-1-antitrypsin (alpha 1), suggesting that the CDF activity is not due to tryptic serine proteases, although it may be protease susceptible. The heparanase inhibitor, heparin, inhibited CD4+ T cell-mediated astrocyte detachment at low doses, but augmented detachment at higher doses, indicating that detaching activity is not due to heparanases. The actin microfilament disrupting agent, cytochalasin B (CB), inhibited astrocyte detachment induced by MBP-specific CD4+ T cells. CB pretreatment of the target astrocytes, but not of the effector CD4+ T cells, inhibited astrocyte detachment, suggesting that the integrity of the target's, but not the effector's, cytoskeleton is required for astrocyte detachment. The results herein suggest that during astrocyte interaction with MBP-specific CD4+ T cells, soluble factors are released that trigger an intrinsic astrocyte detachment mechanism.
我们已经表明,致脑炎的、髓鞘碱性蛋白(MBP)特异性的CD4+ T细胞在体外可导致星形胶质细胞和少突胶质细胞脱离。类似的过程可能在体内通过引起脑组织结构的紊乱和破坏而损害中枢神经系统(CNS)。“旁观者”同种异体纤维肉瘤细胞仅在同基因星形胶质细胞存在时才被MBP特异性CD4+ T细胞脱离,这一发现表明,在特异性星形胶质细胞与CD4+效应细胞相互作用过程中会释放一种可溶性细胞脱离因子(CDF)。在本研究中,在与伴刀豆球蛋白A或星形胶质细胞一起孵育的MBP反应性CD4+ T细胞的上清液中检测到了CDF活性。蛋白质合成抑制剂环己酰亚胺和嘌呤霉素抑制淋巴细胞诱导的星形胶质细胞裂解,但不抑制其脱离,这表明这种类型的裂解需要从头合成蛋白质,但脱离不需要。胰蛋白酶抑制剂大豆胰蛋白酶抑制剂(SBTI)和α1抗胰蛋白酶(α1)并不抑制星形胶质细胞脱离,反而增强了脱离,这表明CDF活性不是由胰蛋白酶丝氨酸蛋白酶引起的,尽管它可能对蛋白酶敏感。硫酸乙酰肝素酶抑制剂肝素在低剂量时抑制CD4+ T细胞介导的星形胶质细胞脱离,但在高剂量时增强脱离,这表明脱离活性不是由硫酸乙酰肝素酶引起的。肌动蛋白微丝破坏剂细胞松弛素B(CB)抑制MBP特异性CD4+ T细胞诱导的星形胶质细胞脱离。对靶星形胶质细胞而非效应CD4+ T细胞进行CB预处理可抑制星形胶质细胞脱离,这表明星形胶质细胞脱离需要靶细胞而非效应细胞的细胞骨架的完整性。本文结果表明,在星形胶质细胞与MBP特异性CD4+ T细胞相互作用过程中,会释放可溶性因子,触发星形胶质细胞内在的脱离机制。